Taking Too Much Semaglutide: What Counts as an Overdose and What to Do

What actually happens if you take too much semaglutide?

Semaglutide works by activating GLP-1 receptors in the gut and brain, slowing gastric emptying and reducing appetite. Taking a higher dose than prescribed amplifies all of those effects simultaneously. The result is usually an intense version of the side effects that many people experience in the first week on any new pen: severe nausea, repeated vomiting, diarrhoea and abdominal cramping that becomes difficult to manage at home.

In people who are also taking insulin or certain diabetes medicines, an overdose on Wegovy creates an additional risk of hypoglycaemia (low blood sugar), because semaglutide has a blood-sugar-lowering effect of its own. Symptoms of hypoglycaemia include shakiness, sweating, confusion and, in serious cases, loss of consciousness. This is a medical emergency.

Prolonged, severe vomiting or diarrhoea from any cause can lead to dehydration and, in turn, stress on the kidneys. The NHS guidance on semaglutide lists dehydration from GI illness as a reason to seek urgent help, even at normal therapeutic doses. At a higher accidental dose, the risk escalates. There is currently no licensed antidote to semaglutide; a medical team will manage symptoms supportively, which is why professional assessment matters rather than waiting it out at home.

The realistic overdose scenarios: how this tends to happen

In clinical practice, a Wegovy overdose is rarely a deliberate act. The more common situations involve an extra injection administered by mistake, a dose escalated ahead of schedule, or a pen used in a different concentration than the person expected. Pre-filled semaglutide pens hold four weekly doses; if someone injects on the wrong day and loses track, they may take two injections within a short window.

Accidental double-dosing is exactly the kind of mistake that a well-structured prescribing relationship is designed to prevent. At nume, sorry, at our pharmacy, a prescriber reviews your treatment before every repeat, checking the timeline of your doses against what you report. That review catches potential escalation errors before a pen is dispatched. You can also read about the overall framework behind Wegovy as a treatment, including how the titration schedule is designed to be protective, not just incremental.

A subtler scenario involves self-accelerating the titration, and it is worth knowing that the schedule from semaglutide 1mg upward exists partly to let your body adjust at each level; pushing ahead faster than prescribed does not improve results and meaningfully increases the chance of severe GI effects that resemble overdose symptoms in their intensity. Your prescriber, not a personal sense of impatience, should be the one deciding when a dose increase is appropriate.

Symptoms that mean you should not wait: when to act immediately

This is the practical decision the page title frames. If you have taken more semaglutide than intended, the question is not whether you feel unwell yet, but whether you need assessment now or later. The answer is: now, or as soon as possible.

Call NHS 111 immediately, or go to A&E, if you experience any of the following after a suspected overdose on Wegovy: severe or persistent vomiting you cannot control, signs of hypoglycaemia (shaking, confusion, pale skin, rapid heartbeat), severe stomach pain that radiates toward the back, signs of a serious allergic reaction (throat tightening, face swelling, difficulty breathing), or any loss of consciousness. Take your pen, packaging and any other medicines with you so that the team treating you knows exactly what and how much you took.

For milder over-exposure where symptoms are uncomfortable but manageable, contacting NHS 111 for guidance is still the right step. You can also reach our clinical team through our contact page if you are already a patient and need to speak to someone about your treatment.

The MHRA's Yellow Card scheme allows patients and carers to report suspected adverse reactions, including those from accidental overdose. Reporting helps regulators monitor the real-world safety profile of medicines like Wegovy.

How supervised prescribing keeps doses where they should be

The reason the titration schedule for semaglutide starts at 0.25mg and steps upward slowly over months is protective: most of the GI side effects that people find difficult are dose-dependent and time-dependent. Your body adjusts. Moving through the schedule under clinical supervision, with a prescriber checking in before each step, makes it far less likely that you end up at a dose your system is not ready for.

That protection is also the reason prescription-only status exists. Semaglutide bought from sellers who supply it without clinical assessment carries a much higher risk of dosing error, in addition to the product-authenticity risks that the MHRA has warned about publicly. A recent enforcement operation seized around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million, and counterfeit pens have been found to contain incorrect or harmful substances. Safe supply and a properly managed titration schedule, including understanding what semaglutide 2mg involves before you reach that stage, are not separate considerations; they reinforce each other.

If you are considering starting Wegovy and want to understand how private treatment costs are structured in the UK, that context is useful reading before you commit to any provider. And if you would like to explore what treatment looks like with clinical oversight from the start, start your free consultation with our prescribers.